Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as obesity and diabetes mellitus, leading to increased mortality. Antipsychotics (APs), which are the mainstay in the tre...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Raghunath Singh, Nicolette Stogios, Emily Smith, Jiwon Lee, Kateryna Maksyutynsk, Emily Au, David C. Wright, Giada De Palma, Ariel Graff-Guerrero, Philip Gerretsen, Daniel J. Müller, Gary Remington, Margaret Hahn, Sri Mahavir Agarwal
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	SAGE Publishing 2022-05-01
Serie:	Therapeutic Advances in Psychopharmacology
Accesso online:	https://doi.org/10.1177/20451253221096525
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!